Product image of Ofloxacina Viatris (Ofloxacin) supplied by GNH India

Ofloxacina Viatris

Active Ingredient:
Ofloxacin
Origin:
EU

Ofloxacina Viatris (Ofloxacin)

Ofloxacin, the active ingredient in Ofloxacina Viatris, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats a range of bacterial infections in adults and children when prescribed by a qualified health professional. Ofloxacina Viatris is manufactured under EU regulations and complies with international quality standards.

GNH India supplies Ofloxacina Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Viatris Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ofloxacina Viatris is a fluoroquinolone antibiotic used to manage infections caused by susceptible bacteria.

  • Urinary tract infection: eradicates common uropathogens and resolves symptoms.
  • Acute bacterial sinusitis: reduces bacterial load and improves sinus drainage.
  • Skin and soft‑tissue infection: treats cellulitis and wound infections caused by Gram‑negative and Gram‑positive organisms.
  • Chronic bacterial prostatitis: penetrates prostatic tissue to eliminate infection.
  • Uncomplicated gonorrhea: provides rapid bacterial clearance in genital infections.

How It Works

  • Ofloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, and repair. This inhibition leads to DNA strand breakage and ultimately bacterial cell death, providing a bactericidal action against a broad spectrum of Gram‑negative and Gram‑positive organisms.

Side Effects

Adverse reactions may occur with Ofloxacina Viatris and are categorized by frequency and severity.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools, often self‑limiting.
  • Headache: transient cranial discomfort.
  • Dizziness: occasional light‑headedness.
  • Rash: mild skin erythema.
  • Photosensitivity: increased sun sensitivity.

Serious or Rare Side Effects

  • Tendon rupture: especially Achilles tendon, may occur during or after therapy.
  • QT interval prolongation: risk of cardiac arrhythmia.
  • Central nervous system effects: seizures or severe confusion.
  • Severe allergic reactions: anaphylaxis, angioedema.
  • Clostridioides difficile colitis: severe intestinal infection.
  • Hepatotoxicity: elevated liver enzymes or jaundice.

Precautions & Warnings

Before prescribing Ofloxacina Viatris, clinicians should consider patient‑specific factors and safety measures.

  • Tendon health: avoid use in patients with recent tendon injury or corticosteroid therapy.
  • Cardiac risk: assess QT interval in patients with known arrhythmias.
  • Renal function: adjust use in severe renal impairment.
  • Pregnancy and lactation: contraindicated unless benefits outweigh risks.
  • Drug hypersensitivity: review history of fluoroquinolone allergy.
  • Store at ambient temperature: keep below 25°C, retain original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Ofloxacina Viatris may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Antacids containing aluminum or magnesium: reduce absorption of ofloxacin.
  • NSAIDs (e.g., ibuprofen, diclofenac): increase risk of central nervous system stimulation.
  • Warfarin: may enhance anticoagulant effect, requiring INR monitoring.

Moderate Interactions (Monitor Closely)

  • Corticosteroids: heightened risk of tendon rupture.
  • Theophylline: possible increase in plasma concentrations.
  • Cyclosporine: may raise cyclosporine levels, necessitating dose adjustment.

Frequently Asked Questions

Ofloxacina Viatris is indicated for bacterial infections such as urinary tract infections, acute bacterial sinusitis, skin and soft‑tissue infections, chronic bacterial prostatitis, and uncomplicated gonorrhea, when the causative organisms are susceptible to ofloxacin.

Ofloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. This inhibition leads to DNA damage and bacterial cell death, providing a broad‑spectrum bactericidal effect.

The dosage of Ofloxacina Viatris is determined by the prescribing clinician based on the infection type, severity, patient age, renal function and other clinical factors. Patients should follow the prescriber’s instructions precisely.

Ofloxacin is generally contraindicated in pregnancy and lactation unless the potential benefit justifies the risk. Clinicians should evaluate alternative therapies and discuss potential risks with the patient.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ofloxacina Viatris (ofloxacin) shares the class‑wide mechanism of DNA gyrase inhibition but differs in pharmacokinetic profile and spectrum. Compared with ciprofloxacin, ofloxacin offers similar efficacy with a slightly broader Gram‑positive coverage, while maintaining comparable safety when used appropriately.

Store tablets at ambient temperature below 25 °C, in the original container, protected from moisture and direct sunlight. Do not refrigerate or expose to extreme heat.

Ofloxacina Viatris is supplied as oral tablets and should be taken with a full glass of water. It may be taken with or without food, but antacids containing aluminum or magnesium should be spaced at least two hours apart to avoid reduced absorption.

Serious risks include tendon rupture, especially in the Achilles tendon, QT interval prolongation leading to arrhythmias, severe allergic reactions such as anaphylaxis, and Clostridioides difficile‑associated colitis. Patients should be monitored for these events and advised to seek immediate medical attention if they occur.

Patients with a known hypersensitivity to fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, individuals with uncontrolled cardiac arrhythmias, and pregnant or breastfeeding women (unless benefits outweigh risks) should avoid Ofloxacina Viatris.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ofloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT